These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27884799)

  • 1. The infectious hypoxia: occurrence and causes during Shigella infection.
    Arena ET; Tinevez JY; Nigro G; Sansonetti PJ; Marteyn BS
    Microbes Infect; 2017 Mar; 19(3):157-165. PubMed ID: 27884799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shigella interaction with intestinal epithelial cells determines the innate immune response in shigellosis.
    Fernandez MI; Sansonetti PJ
    Int J Med Microbiol; 2003 Apr; 293(1):55-67. PubMed ID: 12755366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular Aspects of Shigella Pathogenesis: Focus on the Manipulation of Host Cell Processes.
    Killackey SA; Sorbara MT; Girardin SE
    Front Cell Infect Microbiol; 2016; 6():38. PubMed ID: 27066460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?
    Phalipon A; Sansonetti PJ
    Immunol Cell Biol; 2007; 85(2):119-29. PubMed ID: 17213832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Shigella Utilizes Ca(2+) Jagged Edge Signals during Invasion of Epithelial Cells.
    Bonnet M; Tran Van Nhieu G
    Front Cell Infect Microbiol; 2016; 6():16. PubMed ID: 26904514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis, genetics of virulence, and immunity in Shigellosis.
    Formal SB; Kapfer C; Hale TL
    Kansenshogaku Zasshi; 1988 Mar; 62 Suppl():329-42. PubMed ID: 3138359
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental approach in studies on pathogenesis of bacillary dysentery--with special references to the invasion of bacilli into intestinal mucosa.
    Ogawa H
    Acta Pathol Jpn; 1970 Aug; 20(3):261-77. PubMed ID: 4994630
    [No Abstract]   [Full Text] [Related]  

  • 8. Shigella Pathogenesis Modeling with Tissue Culture Assays.
    Koestler BJ; Ward CM; Payne SM
    Curr Protoc Microbiol; 2018 Aug; 50(1):e57. PubMed ID: 29927109
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Brunner K; Samassa F; Sansonetti PJ; Phalipon A
    Hum Vaccin Immunother; 2019; 15(6):1317-1325. PubMed ID: 30964713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shigella infection of intestinal epithelium and circumvention of the host innate defense system.
    Ashida H; Ogawa M; Mimuro H; Sasakawa C
    Curr Top Microbiol Immunol; 2009; 337():231-55. PubMed ID: 19812985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current aspects of Shigella pathogenesis.
    Torres AG
    Rev Latinoam Microbiol; 2004; 46(3-4):89-97. PubMed ID: 17061529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shigella are versatile mucosal pathogens that circumvent the host innate immune system.
    Ashida H; Ogawa M; Mimuro H; Kobayashi T; Sanada T; Sasakawa C
    Curr Opin Immunol; 2011 Aug; 23(4):448-55. PubMed ID: 21763117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental model of keratoconjunctival infections in the study of immunity against Shigella].
    Cefalù M; Puglisi C
    G Mal Infett Parassit; 1972 Apr; 24(4):281-9. PubMed ID: 5050309
    [No Abstract]   [Full Text] [Related]  

  • 14. Exploitation of host factors for efficient infection by Shigella.
    Adam T
    Int J Med Microbiol; 2001 Sep; 291(4):287-98. PubMed ID: 11680789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Orchestra and Its Maestro: Shigella's Fine-Tuning of the Inflammasome Platforms.
    Hermansson AK; Paciello I; Bernardini ML
    Curr Top Microbiol Immunol; 2016; 397():91-115. PubMed ID: 27460806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Galleria mellonella larvae as an in vivo model for evaluation of Shigella virulence.
    Barnoy S; Gancz H; Zhu Y; Honnold CL; Zurawski DV; Venkatesan MM
    Gut Microbes; 2017 Jul; 8(4):335-350. PubMed ID: 28277944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Riboregulators: Fine-Tuning Virulence in Shigella.
    Fris ME; Murphy ER
    Front Cell Infect Microbiol; 2016; 6():2. PubMed ID: 26858941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection.
    Chitradevi ST; Kaur G; Uppalapati S; Yadav A; Singh D; Bansal A
    Cell Mol Immunol; 2015 Nov; 12(6):757-67. PubMed ID: 25640657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidysentery immunoprophylaxis in the light of current data about the pathogenicity of Shigella and the antidysentery immunity.
    Meitert T
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):195-230. PubMed ID: 6443688
    [No Abstract]   [Full Text] [Related]  

  • 20. ShiA abrogates the innate T-cell response to Shigella flexneri infection.
    Ingersoll MA; Zychlinsky A
    Infect Immun; 2006 Apr; 74(4):2317-27. PubMed ID: 16552062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.